Similarly, in the METABRIC cohort and in the Metastatic Breast Cancer project (MBCP) cohort OC2 mRNA levels are significantly higher in tumors where ER expression is suppressed (Fig. 3H, I). Here, ESR1 is linked to breast cancer.